Sector
PharmaceuticalsOpen
₹93.28Prev. Close
₹88.84Turnover(Lac.)
₹3.82Day's High
₹93.28Day's Low
₹93.252 Week's High
₹93.2852 Week's Low
₹10.71Book Value
₹21.77Face Value
₹10Mkt Cap (₹ Cr.)
41.42P/E
87.18EPS
1.07Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 4.66 | 4.66 | 4.66 | 4.66 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 4.82 | 4.47 | 4.62 | 4.14 |
Net Worth | 9.48 | 9.13 | 9.28 | 8.8 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 6.59 | 5.08 | 5.09 | 5.08 |
yoy growth (%) | 29.71 | -0.08 | 0.15 | 1.41 |
Raw materials | -3.49 | -2.33 | -2.5 | -2.42 |
As % of sales | 52.96 | 45.99 | 49.22 | 47.63 |
Employee costs | -1.01 | -0.87 | -0.71 | -0.79 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 0.54 | 0.37 | 0.34 | 0.34 |
Depreciation | -0.26 | -0.26 | -0.23 | -0.21 |
Tax paid | -0.12 | -0.07 | -0.06 | -0.05 |
Working capital | 0.21 | 0.13 | 0.39 | -0.4 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 29.71 | -0.08 | 0.15 | 1.41 |
Op profit growth | 21 | 12.82 | 4.95 | -9 |
EBIT growth | 32.3 | 13.48 | 2.71 | -7.68 |
Net profit growth | 37.87 | 7.6 | 0.6 | -3.37 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,705.55 | 95.71 | 4,09,218.58 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,600.65 | 79.35 | 1,75,226.52 | 667 | 0.45 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,741.9 | 63.7 | 1,26,637.21 | 551 | 0.16 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,554.2 | 24.3 | 1,25,540.69 | 1,303.13 | 1.03 | 4,501.66 | 397.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.85 | 15.39 | 1,06,062.83 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Tosh Kumar Jain
Whole-time Director
Monika Jain
Whole-time Director
Arihant Kumar Jain
Independent Director
Mohit Kumar
Company Sec. & Compli. Officer
Sohini Bansal
Independent Director
Shruti Gupta
Non Executive Director
Bhumika Parwani
Bhagwant Kuti,
Kankhal,
Uttarakhand - 249408
Tel: 91-1334-243833
Website: http://www.deshrakshak.com
Email: deshrakshak@yahoo.com; dral95@yahoo.com; daral96@y
T-34 2nd Floor,
Okhla Industrial Are, Phase II,
New Delhi - 110020
Tel: 91-011-26387281/83
Website: www.masserv.com
Email: info@massere.com
Summary
The flagship company Desh Rakshak Aushdhalaya Limited of Bhagwant Group was originally started in 1901 as a proprietoryship Concern by late Shri Bhagwant Rai Jain, a well renowned Vaidya Father of Lat...
Read More
Reports by Desh Rakshak Aushdhalaya Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.